No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 15.480
- +0.640+4.31%
Close Dec 20 16:00 ET
- 15.480
- 0.0000.00%
Post 16:13 ET
419.31MMarket Cap-6.64P/E (TTM)
15.800High14.610Low812.43KVolume14.700Open14.840Pre Close12.54MTurnover3.28%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.60P/B383.92MFloat Cap14.30052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM8.02%Amplitude4.110Historical Low15.436Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)
Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.
Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Cantor Fitzgerald Reiterates Overweight on Arcturus Therapeuticsto Overweight
Arcturus Therapeutics Analyst Ratings
This Arcturus Therapeutics Holdings Insider Reduced Their Stake By 18%
Heat List
US
Overall
Symbol
Price
% Chg
No Data